Relative to its peers, NVGN does not have very much institutional sponsorship. The 1.08% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
| Other institutional | 0.74% |
| Mutual fund holders | 0.34% |
| Individual stakeholders | -- |